Literature DB >> 4983716

Metabolism of sphingolipids by normal and atherosclerotic aorta of squirrel monkeys.

O W Portman, M Alexander.   

Abstract

We studied the synthesis and hydrolysis of sphingomyelin by homogenates of aortic intima plus inner media from normal squirrel monkeys and from monkeys with nutritionally-induced atherosclerosis (6-10 mo on a semi-purified diet containing butter and cholesterol). The concentrations of sphingomyelin in the aortas and plasmas of the atherosclerotic monkeys were higher than those for the normal monkeys. Palmitoyl-1-(14)C coenzyme A was actively utilized for the synthesis of ceramide (N-palmitoyl sphingosine). The addition of sphingosylphosphorylcholine increased the utilization of palmitoyl CoA in sphingomyelin synthesis, and the addition of psychosine (sphingosyl galactoside) increased the incorporation of palmitate into cerebrosides. Rates of sphingomyelin and ceramide synthesis were significantly higher in the atherosclerotic than in the control aortas. Hydrolysis of labeled sphingomyelin to ceramide was also increased in homogenates of the atherosclerotic aortas. Labeled sphingomyelin was taken up from plasma by everted carotid arteries, and this process was also enhanced by atherosclerosis. Increased rates of synthesis and of uptake from plasma of sphingomyelin may account for the increased concentrations of sphingomyelin in the atherosclerotic arteries, even though the ability to degrade sphingomyelin is also enhanced in the atherosclerotic aorta.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4983716

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

Review 1.  The response-to-retention hypothesis of early atherogenesis.

Authors:  K J Williams; I Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-05       Impact factor: 8.311

2.  ORMDL orosomucoid-like proteins are degraded by free-cholesterol-loading-induced autophagy.

Authors:  Shuhui Wang; Peggy Robinet; Jonathan D Smith; Kailash Gulshan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-09       Impact factor: 11.205

3.  The uptake and metabolism of plasma lysophosphatidylcholine in vivo by the brain of squirrel monkeys.

Authors:  D R Illingworth; O W Portman
Journal:  Biochem J       Date:  1972-11       Impact factor: 3.857

4.  A review of lipidomic technologies applicable to sphingolipidomics and their relevant applications.

Authors:  Xianlin Han; Xuntian Jiang
Journal:  Eur J Lipid Sci Technol       Date:  2009       Impact factor: 2.679

5.  Alkaline methanolysis of lipid extracts extends shotgun lipidomics analyses to the low-abundance regime of cellular sphingolipids.

Authors:  Xuntian Jiang; Hua Cheng; Kui Yang; Richard W Gross; Xianlin Han
Journal:  Anal Biochem       Date:  2007-08-22       Impact factor: 3.365

Review 6.  Hypothalamic malonyl-CoA and the control of food intake.

Authors:  Su Gao; Timothy H Moran; Gary D Lopaschuk; Andrew A Butler
Journal:  Physiol Behav       Date:  2013-08-27

7.  Adenoviral expression of human lecithin-cholesterol acyltransferase in nonhuman primates leads to an antiatherogenic lipoprotein phenotype by increasing high-density lipoprotein and lowering low-density lipoprotein.

Authors:  Marcelo J A Amar; Robert D Shamburek; Boris Vaisman; Catherine L Knapper; Bernhard Foger; Robert F Hoyt; Silvia Santamarina-Fojo; Hollis B Brewer; Alan T Remaley
Journal:  Metabolism       Date:  2009-04       Impact factor: 8.694

8.  Multi-Timepoint Metabolic Fingerprinting of a Post-Episode Period of Hypoglycemia and Ketoacidosis Among Children With Type 1 Diabetes.

Authors:  Beata Małachowska; Karolina Pietrowska; Wojciech Młynarski; Agnieszka Szadkowska; Adam Krętowski; Michał Ciborowski; Wojciech Fendler
Journal:  Front Mol Biosci       Date:  2022-06-23

Review 9.  Sphingolipids in Atherosclerosis: Chimeras in Structure and Function.

Authors:  Lisa Peters; Wolfgang M Kuebler; Szandor Simmons
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

10.  Cysteamine inhibits lysosomal oxidation of low density lipoprotein in human macrophages and reduces atherosclerosis in mice.

Authors:  Yichuan Wen; Feroz Ahmad; Zahra Mohri; Peter D Weinberg; David S Leake
Journal:  Atherosclerosis       Date:  2019-09-26       Impact factor: 5.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.